Evolus Receives Regulatory Approval For Nuceiva In Australia
Australia among the largest countries in the world for aesthetic neurotoxins1
Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,